J. Deanna Wilson

About

J. Deanna Wilson, MD, MPH, is a Presidential Assistant Professor in the Department of Family Medicine and Community Health at the Perelman School of Medicine at the University of Pennsylvania. Her clinical expertise encompasses addiction medicine across the life spectrum, including substance use and substance use disorder treatment in adolescents and young adults, in both office-based and hospital-based settings. Her research leverages traditional health services research methods, community-engaged research, and implementation science to promote health equity for marginalized and racially minoritized populations who use drugs. Her work focuses on integrating harm reduction into primary care and hospital settings, developing low-threshold models of care to improve engagement and retention among marginalized groups, and enhancing treatment engagement for adolescents and young adults with opioid use disorder. She has contributed to advancing understanding of stigma's impact on harm reduction practices and has been involved in community-based interventions aimed at improving health outcomes for people who use drugs.

Research topics

• Medicine
• Psychiatry
• Family medicine
• Psychology
• Emergency medicine

Selected publications

• Management of Opioid Misuse and Opioid Use Disorders Among Youth

  PEDIATRICS · 2020-05-01 · 44 citations

  articleOpen accessSenior author

  In response to the growing impact of the current opioid public health crisis in the United States on adolescents and young adults, pediatricians have an expanding role in identifying opioid use early, preventing escalation of risky use, reducing opioid-related harms, and delivering effective therapies. Research and expert consensus suggest the use of brief interventions focused on reducing risks associated with ongoing opioid use and using motivational interviewing strategies to engage youth in…

  PublisherOA PDFDOI

• Racial Diversity Among American Cardiologists: Implications for the Past, Present, and Future

  Circulation · 2021-06-14 · 41 citations

  articleOpen access

  In the United States, race-based disparities in cardiovascular disease care have proven to be pervasive, deadly, and expensive. African American/Black, Hispanic/Latinx, and Native/Indigenous American individuals are at an increased risk of cardiovascular disease and are less likely to receive high-quality, evidence-based medical care as compared with their White American counterparts. Although the United States population is diverse, the cardiovascular workforce that provides its much-needed car…

  PublisherOA PDFDOI

• Community pharmacists’ attitudes toward and practice of pharmacy-based harm reduction services in Pittsburgh, PA: a descriptive survey

  Harm Reduction Journal · 2024-07-19 · 8 citations

  articleOpen accessSenior author

  BACKGROUND: In Pittsburgh, PA, legal changes in recent decades have set the stage for an expanded role for community pharmacists to provide harm reduction services, including distributing naloxone and non-prescription syringes (NPS). In the wake of the syndemics of the COVID-19 pandemic and worsening overdose deaths from synthetic opioids, we examine knowledge, attitudes, and practices of harm reduction services among community pharmacists in Pittsburgh and identify potential barriers of expande…

  PublisherOA PDFDOI

• “We’re Not Gonna Aid You in Shooting Up”: Stigma’s Relationship to Harm Reduction in People Who Inject Drugs

  Journal of General Internal Medicine · 2024-10-24 · 6 citations

  articleOpen accessSenior author
  PublisherOA PDFDOI

• Study Protocol for Pain Self-Management and Patient-Oriented Buprenorphine Dosing for Pain and Retention in Office-Based Opioid Treatment: A Hybrid Type 1, 2 × 2 Factorial Randomized Controlled Trial

  Substance Use &amp Addiction Journal · 2024-06-22 · 4 citations

  articleOpen access

  Chronic pain is a significant factor for patients with opioid use disorder (OUD) contributing to suboptimal retention in buprenorphine treatment, which is a crucial predictor of long-term health outcomes. This study aims to address the critical need for effective interventions targeting chronic pain management within office-based opioid treatment (OBOT) programs. We are conducting a multisite, hybrid type 1, 2 × 2 factorial randomized clinical trial to determine the effectiveness of 2 novel inte…

  PublisherOA PDFDOI

Recent grants

• Treatment of Opioid Use Disorder in Young Adults Hospitalized with Infectious Complications of Injection Opioid Use

  NIH · $570k · 2020–2024

• THRIVE: Teaching Health promotion and Resilience in Varied Environments: a peer-led intervention following hospital discharge

  NIH · $3.0M · 2022–2027

Frequent coauthors

• Emily Rider-Longmaid

  University of Pennsylvania

  9 shared

• Jane M. Liebschutz

  University of Pittsburgh

  8 shared

• Leonard Feldman

  Johns Hopkins Medicine

  6 shared

• Anika Alvanzo

  Johns Hopkins Medicine

  6 shared

• Jessica S. Merlin

  University of Pittsburgh

  6 shared

• Natalie Spicyn

  University of Maryland, Baltimore

  5 shared

• Pamela A. Matson

  Johns Hopkins University

  5 shared

• Lydia H. Pecker

  Johns Hopkins Medicine

  4 shared

Labs

• Wilson LabPI

Awards & honors

• Presidential Assistant Professor

Similar researchers at University of Pennsylvania

• John Q. Trojanowskih-296
• Craig B. Thompsonh-277
• Daniel J Raderh-236